Copyright © 2021. Inderes Oyj. All rights reserved.

Revenio Group

Latest reports

Extensive report

Analyst

Juha Kinnunen

Juha Kinnunen

Osakestrategi, analyytikko

Read more

Viimeisin video

Latest insider trading

Net impact profile

Stock release
4.8.
2021

Revenio Group Corporation, Stock Exchange Release, August 4, 2021 at 20.10

Revenio updates its financial guidance for the year 2021

Revenio Group’s exchange rate adjusted net sales are estimated to grow very strongly from the previous year and profitability is to remain at a good level without non-recurring items. COVID-19 pandemic continues to cause uncertainty related to the markets.

Previous earnings guidance published on April 23, 2021:

Stock release
27.7.
2021

Revenio Group Corporation, Press release, July 27, 2021 at 9.00

Invitation to Revenio’s audiocast and teleconference in relation to the half-year financial report 2021

Revenio Group Corporation’s half-year financial report 2021 on Thursday, 5 August 2021, approximately at 9:00 am.

An audiocast and teleconference for analytics and investors is held in English at 3:00 pm on the same day.

Stock release
18.6.
2021

Revenio Group Corporation, Stock Exchange Release, June 18, 2021 at 10.30

Hanna Vuornos appointed Director, People&Culture and as a member of the Management Team

Master of Social Sciences Hanna Vuornos (born 1978) has been appointed Director, People&Culture of the Revenio Group and as a member of the Group’s Management Team. Hanna will begin in her new position on August 16, 2021.

Stock release
15.6.
2021

Revenio Group Corporation, Stock Exchange Release, June 15, 2021 at 9:00

INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER

Company report
15.6.
2021

Revenio is known as the global beacon of tonometers but these days the company is a noteworthy challenger in more extensive ophthalmic health technology. Imaging tools (previous CenterVue) play an increasing role in future growth and HOME products, as well as software business offer longer term growth promises. Business is growing very profitably, the market has sound growth drivers, and the products have strong competitive advantages.

Stock release
28.5.
2021

Revenio Group Corporation, Stock Exchange Release, May 28, 2021 at 14.05

Transfer of the Company's own shares

Revenio Group Corporation has transferred on May 26, 2021 1,046 shares (REG1V) to the members of the Board of Directors as part of remuneration of the Board.

Stock release
28.5.
2021

Revenio Group Corporation, Stock exchange release, May 28, 2021 at 11.45

Appointment to Revenio’s Leadership Team

Dr Kate Taylor MBBS MPH, (b. 1971), Director of Eye Care Solutions, has been appointed to Revenio’s Leadership Team. She is the Co-Founder of Oculo, acquired by Revenio in April.

Stock release
3.5.
2021

Revenio Group Corporation, Stock Exchange Release, May 3, 2021 at 16.05

Stock release
3.5.
2021

Revenio Group Corporation, Stock Exchange Release, May 3, 2021 at 14.35

Stock release
30.4.
2021

Revenio Group Corporation, Stock Exchange Release, April 30, 2021 at 13.15

Revenio Group